Improved detection of gene fusions by applying statistical methods reveals oncogenic RNA cancer drivers
暂无分享,去创建一个
E. Lehnert | J. Salzman | Roozbeh Dehghannasiri | Milos Jordanski | D. Freeman | G. Hsieh | Ana Damljanovic
[1] C. Grandori,et al. CDK12: an emerging therapeutic target for cancer , 2018, Journal of Clinical Pathology.
[2] Li Ding,et al. Driver Fusions and Their Implications in the Development and Treatment of Human Cancers , 2018, Cell reports.
[3] J. Mendell,et al. Functional Classification and Experimental Dissection of Long Noncoding RNAs , 2018, Cell.
[4] Liuqing Yang,et al. Long Noncoding RNA in Cancer: Wiring Signaling Circuitry. , 2017, Trends in cell biology.
[5] Ming Tang,et al. TumorFusions: an integrative resource for cancer-associated transcript fusions , 2017, Nucleic Acids Res..
[6] A. Sethi,et al. The Cancer Genomics Cloud: Collaborative, Reproducible, and Democratized-A New Paradigm in Large-Scale Computational Research. , 2017, Cancer research.
[7] Russell Bonneville,et al. Landscape of Microsatellite Instability Across 39 Cancer Types. , 2017, JCO precision oncology.
[8] Bauke Ylstra,et al. Postmortem Examination of an Aggressive Case of Medullary Thyroid Carcinoma Characterized by Catastrophic Genomic Abnormalities. , 2017, JCO precision oncology.
[9] E. A. Sweet-Cordero,et al. Statistical algorithms improve accuracy of gene fusion detection , 2017, Nucleic acids research.
[10] Moriah H Nissan,et al. OncoKB: A Precision Oncology Knowledge Base. , 2017, JCO precision oncology.
[11] Timothy L. Tickle,et al. STAR-Fusion: Fast and Accurate Fusion Transcript Detection from RNA-Seq , 2017, bioRxiv.
[12] Elaine R. Mardis,et al. Applications of Immunogenomics to Cancer , 2017, Cell.
[13] C. Bonifer,et al. The Transcriptome Heterogeneity of MLL-Fusion ALL Is Driven By Fusion Partners Via Distinct Chromatin Binding , 2016 .
[14] Sanghyuk Lee,et al. ChimerDB 3.0: an enhanced database for fusion genes from cancer transcriptome and literature data mining , 2016, Nucleic Acids Res..
[15] Erik Larsson,et al. Global analysis of somatic structural genomic alterations and their impact on gene expression in diverse human cancers , 2016, Proceedings of the National Academy of Sciences.
[16] Rui-Xi Hua,et al. Long Intergenic Noncoding RNA 00511 Acts as an Oncogene in Non–small-cell Lung Cancer by Binding to EZH2 and Suppressing p57 , 2016, Molecular therapy. Nucleic acids.
[17] Jin Zhang,et al. INTEGRATE-neo: a pipeline for personalized gene fusion neoantigen discovery , 2016, Bioinform..
[18] A. Chak,et al. RNA Sequencing Identifies Transcriptionally Viable Gene Fusions in Esophageal Adenocarcinomas. , 2016, Cancer research.
[19] Nicola D. Roberts,et al. Genomic Classification and Prognosis in Acute Myeloid Leukemia. , 2016, The New England journal of medicine.
[20] M. Babu,et al. Discovering and understanding oncogenic gene fusions through data intensive computational approaches , 2016, Nucleic acids research.
[21] R. Gibbs,et al. Genomic analyses identify molecular subtypes of pancreatic cancer , 2016, Nature.
[22] Paul Medvedev,et al. TwoPaCo: an efficient algorithm to build the compacted de Bruijn graph from many complete genomes , 2016, Bioinform..
[23] Hui Li,et al. Comparative assessment of methods for the fusion transcripts detection from RNA-Seq data , 2016, Scientific Reports.
[24] Carl Kingsford,et al. Fast Search of Thousands of Short-Read Sequencing Experiments , 2015, Nature Biotechnology.
[25] Adrian V. Lee,et al. Comprehensive evaluation of fusion transcript detection algorithms and a meta-caller to combine top performing methods in paired-end RNA-seq data , 2015, Nucleic acids research.
[26] Maite Huarte. The emerging role of lncRNAs in cancer , 2015, Nature Medicine.
[27] V. Beral,et al. Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer , 2015, Nature Reviews Cancer.
[28] Zhihong Wu,et al. FusionCancer: a database of cancer fusion genes derived from RNA-seq data , 2015, Diagnostic Pathology.
[29] L. Laurent,et al. Statistically based splicing detection reveals neural enrichment and tissue-specific induction of circular RNA during human fetal development , 2015, Genome Biology.
[30] Wei-De Zhong,et al. miR-195 Inhibits Tumor Progression by Targeting RPS6KB1 in Human Prostate Cancer , 2015, Clinical Cancer Research.
[31] M. Stratton,et al. High burden and pervasive positive selection of somatic mutations in normal human skin , 2015, Science.
[32] Liuqing Yang,et al. lncRNA Directs Cooperative Epigenetic Regulation Downstream of Chemokine Signals , 2014, Cell.
[33] R. Verhaak,et al. The landscape and therapeutic relevance of cancer-associated transcript fusions , 2014, Oncogene.
[34] Mingming Jia,et al. COSMIC: exploring the world's knowledge of somatic mutations in human cancer , 2014, Nucleic Acids Res..
[35] Hai Fang,et al. dcGOR: An R Package for Analysing Ontologies and Protein Domain Annotations , 2014, PLoS Comput. Biol..
[36] Nicolas Stransky,et al. The landscape of kinase fusions in cancer , 2014, Nature Communications.
[37] John N. Weinstein,et al. PRADA: pipeline for RNA sequencing data analysis , 2014, Bioinform..
[38] S. Gabriel,et al. Discovery and saturation analysis of cancer genes across 21 tumor types , 2014, Nature.
[39] Cory B. Giles,et al. Systematic classification of non-coding RNAs by epigenomic similarity , 2013, BMC Bioinformatics.
[40] S. Dhanasekaran,et al. The long noncoding RNA SChLAP1 promotes aggressive prostate cancer and antagonizes the SWI/SNF complex , 2013, Nature Genetics.
[41] Benjamin J. Raphael,et al. Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia. , 2013, The New England journal of medicine.
[42] Ellen T. Gelfand,et al. The Genotype-Tissue Expression (GTEx) project , 2013, Nature Genetics.
[43] P. Holst,et al. The rationale of vectored gene-fusion vaccines against cancer: evolving strategies and latest evidence , 2013, Therapeutic advances in vaccines.
[44] Marco Beccuti,et al. State of art fusion-finder algorithms are suitable to detect transcription-induced chimeras in normal tissues? , 2013, BMC Bioinformatics.
[45] A. Sivachenko,et al. Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples , 2013, Nature Biotechnology.
[46] Stephen P. Jackson,et al. Chromothripsis and cancer: causes and consequences of chromosome shattering , 2012, Nature Reviews Cancer.
[47] D. Brat,et al. Transforming Fusions of FGFR and TACC Genes in Human Glioblastoma , 2012, Science.
[48] Enrico Macii,et al. Bellerophontes: an RNA-Seq data analysis framework for chimeric transcripts discovery based on accurate fusion model , 2012, Bioinform..
[49] Benjamin E. Gross,et al. The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. , 2012, Cancer discovery.
[50] Charles Gawad,et al. Circular RNAs Are the Predominant Transcript Isoform from Hundreds of Human Genes in Diverse Cell Types , 2012, PloS one.
[51] S. Lessnick,et al. Promiscuous partnerships in Ewing's sarcoma. , 2011, Cancer genetics.
[52] J. Bergh,et al. Transcriptional consequences of genomic structural aberrations in breast cancer. , 2011, Genome research.
[53] T. Halazonetis,et al. Genomic instability — an evolving hallmark of cancer , 2010, Nature Reviews Molecular Cell Biology.
[54] S. Lessnick,et al. GSTM4 is a microsatellite-containing EWS/FLI target involved in Ewing's sarcoma oncogenesis and therapeutic resistance , 2009, Oncogene.
[55] J. Brooks. Role of the TMPRSS2-ERG gene fusion in prostate cancer , 2008 .
[56] T. Tammela,et al. TMPRSS2:ERG Fusion Identifies a Subgroup of Prostate Cancers with a Favorable Prognosis , 2008, Clinical Cancer Research.
[57] R. Shah,et al. Role of the TMPRSS2-ERG gene fusion in prostate cancer. , 2008, Neoplasia.
[58] Wen-Lin Kuo,et al. Amplification of PVT1 Contributes to the Pathophysiology of Ovarian and Breast Cancer , 2007, Clinical Cancer Research.
[59] H. Aburatani,et al. Identification of the transforming EML4–ALK fusion gene in non-small-cell lung cancer , 2007, Nature.
[60] R. Redon,et al. Relative Impact of Nucleotide and Copy Number Variation on Gene Expression Phenotypes , 2007, Science.
[61] B. Oh,et al. Autophagic and tumour suppressor activity of a novel Beclin1-binding protein UVRAG , 2006, Nature Cell Biology.
[62] M. Shipitsin,et al. Activation of RalA is critical for Ras-induced tumorigenesis of human cells. , 2005, Cancer cell.
[63] J. Thacker. The RAD51 gene family, genetic instability and cancer. , 2005, Cancer letters.
[64] T. Hunter,et al. The Protein Kinase Complement of the Human Genome , 2002, Science.
[65] J. Rowley,et al. Chromosome translocations: dangerous liaisons revisited , 2001, Nature Reviews Cancer.
[66] Y. Benjamini,et al. THE CONTROL OF THE FALSE DISCOVERY RATE IN MULTIPLE TESTING UNDER DEPENDENCY , 2001 .
[67] I. Lax,et al. Critical role for the docking-protein FRS2α in FGF receptor-mediated signal transduction pathways , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[68] N. Henze. A poisson limit law for a generalized birthday problem , 1998 .
[69] Stephen N. Jones,et al. Regulation of p53 stability by Mdm2 , 1997, Nature.
[70] K. Umesono,et al. Chromosomal translocation t(15;17) in human acute promyelocytic leukemia fuses RARα with a novel putative transcription factor, PML , 1991, Cell.
[71] A. Knudson. Mutation and cancer: statistical study of retinoblastoma. , 1971, Proceedings of the National Academy of Sciences of the United States of America.
[72] The National Academy of Sciences , 1928, Science.
[73] P. Nowell,et al. A minute chromosome in human chronic granulocytic leukemia , 1960 .